Deep Tech Fund: Last Call

Overview

Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.

Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.

Funds actively worked on

• Strawberry Creek Ventures
• Deep Tech Fund

Investment Area of Focus

His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.

Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).

Learn How To Invest In Companies In This Sector With Alumni Ventures:

Deep Tech Fund>>>

Overview:

Todd McIntyre invests in transformative technologies that move markets and improve lives—where deep science, hardware innovation, and human health intersect. With 25+ years as both investor and operator, Todd has built, funded, and scaled companies from inception through exit. He focuses on opportunities where differentiated intellectual property and disciplined execution can create lasting value.

Before joining Alumni Ventures as Managing Partner of Spike Ventures (Stanford alumni fund), Todd co-founded Grey Sky Venture Partners, a healthtech venture capital fund that linked equity investment with fund-owned intellectual property. He sourced investments, guided portfolio companies as board member and mentor, and managed a 500+ patent portfolio. Earlier, as Vice President of Business Development at Invention Science Fund, he helped incubate and fund several landmark deep-tech startups, including TerraPower, Kymeta, Evolv Technologies, Echodyne, and Pivotal Commware.

Todd also played a leading role in growing Microvision from a three-person startup to a publicly traded innovator in display and imaging, and founded Lumera Corporation, a spinout focused on optical and biotech device technologies.

Funds Actively Worked On:

• Spike Ventures
• Deep Tech Fund

Investment Lens:

Across healthcare, hardware, and deep tech, Todd backs founders who bring breakthrough ideas into reality. He looks for entrepreneurs who don’t just imagine the future—they engineer it, protect it, and scale it.

Todd’s investment lens emphasizes diversified venture portfolios: sector, stage, geography, and vintage. He has extensive experience negotiating and closing deals across the capital structure—from seed and early-stage ventures to M\&A and public financings. His track record spans pioneering work in healthtech, complex patent licensing transactions, and syndicating deals alongside top-tier venture firms.

Learn How To Invest In Companies In This Sector With Alumni Ventures:

Healthtech Fund>>>
Deep Tech Fund>>>